Bio-Rad Laboratories, Inc. announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The ...

Bio-Rad Laboratories, Inc. has announced the launch of Bio-Plex Pro magnetic bead-based human and mouse cytokine assays. Developed by Bio-Rad scientists, magnetic bead-based immunoassays offer full ...

Bio-Rad Laboratories and Myriad RBM have partnered to develop and distribute immunoassay kits. The agreement combines Myriad RBM’s menu of multiplexed immunoassays with Bio-Rad’s global ...

Bio-Rad Laboratories, Inc. (CA, USA) (NYSE: BIO and BIOb) is announcing the launch of the Reliance One-Step Multiplex Supermix, a highly sensitive and robust reagent mix for detection and ...

Multiplex PCR technologies have been developed to increase the number of RNA or DNA targets that can be quantified within a single well. ... This In Focus, supported by Bio-Rad Laboratories, will ...

"The continued development of the Bio-Rad StarBright Dye portfolio, now totaling 28 dyes and spanning multiple lasers, gives researchers greater choice and flexibility across multiplex flow cytometry ...

“We are proud to add three new dyes to Bio-Rad’s StarBright UltraViolet portfolio, following its launch last year, and are now better positioned to support researchers with their flow cytometry ...

Bio-Rad Laboratories, Inc. announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The panel can identify and ...